Follow the people · Insider
Walter Klemp V
Walter Klemp V files insider transactions with the SEC as a director of Autonomix Medical (AMIX). We hold 1 disclosed purchase or sale filed since 12 May 2017, 1 of them in the last 90 days.
- Files forAMIX
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure8 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 21 June 2024 — 3 September 2026Director · Autonomix Medical (AMIX)3 Form 4 lines · source: SEC Form 4
- Filed 11 May 2017 — 3 August 2026CEO and President · Moleculin Biotech (MBRX)97 Form 4 lines · source: SEC Form 4
- Filed 27 June 2019 — 16 December 2021Executive Chairman · Soliton (SOLY)13 Form 4 lines · source: SEC Form 4
Everything they disclosed
113 entries, newest first — one per disclosure report, one per Form 4 line- was granted 13,000 shares of Autonomix MedicalSEC Form 48 September 2026Common Stock · traded 3 September 2026 · filed 8 September 2026
- ▲ bought on the open market 533,333 shares of Moleculin BiotechSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- was granted 1,599,999 shares of Moleculin Biotech (a derivative holding)SEC Form 45 August 2026Series I Warrants · traded 3 August 2026 · filed 5 August 2026
- exercised options over 150 shares of Moleculin BiotechSEC Form 424 June 2026Common Stock · traded 20 June 2026 · filed 24 June 2026
- had shares withheld for tax on 37 shares of Moleculin BiotechSEC Form 424 June 2026Common Stock · traded 20 June 2026 · filed 24 June 2026
- exercised options over 360 shares of Moleculin BiotechSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- had shares withheld for tax on 88 shares of Moleculin BiotechSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 150 shares of Moleculin Biotech (a derivative holding)SEC Form 424 June 2026Restricted Stock Units · traded 20 June 2026 · filed 24 June 2026
- exercised options over 360 shares of Moleculin Biotech (a derivative holding)SEC Form 424 June 2026Restricted Stock Units · traded 22 June 2026 · filed 24 June 2026
- was granted 830,000 shares of Moleculin Biotech (a derivative holding)SEC Form 414 November 2025Stock option (right to buy) · traded 12 November 2025 · filed 14 November 2025
- was granted 750,000 shares of Moleculin Biotech (a derivative holding)SEC Form 414 November 2025Performance Based Restricted Stock Units · traded 12 November 2025 · filed 14 November 2025
- exercised options over 28,750 shares of Moleculin Biotech (a derivative holding)SEC Form 46 November 2025Restricted Stock Units · traded 4 November 2025 · filed 6 November 2025
- exercised options over 28,750 shares of Moleculin BiotechSEC Form 46 November 2025Common Stock · traded 4 November 2025 · filed 6 November 2025
- had shares withheld for tax on 7,001 shares of Moleculin BiotechSEC Form 46 November 2025Common Stock · traded 4 November 2025 · filed 6 November 2025
- returned to the issuer 8,773 shares of Autonomix Medical (a derivative holding)SEC Form 413 August 2025Option (Right to buy) · traded 11 August 2025 · filed 13 August 2025
- exercised options over 3,750 shares of Moleculin Biotech (a derivative holding)SEC Form 423 June 2025Restricted Stock Units · traded 20 June 2025 · filed 23 June 2025
- exercised options over 8,990 shares of Moleculin Biotech (a derivative holding)SEC Form 423 June 2025Restricted Stock Units · traded 22 June 2025 · filed 23 June 2025
- ▲ bought on the open market 2,027,025 shares of Moleculin Biotech (a derivative holding)SEC Form 423 June 2025Series E Warrants · traded 23 June 2025 · filed 23 June 2025
- exercised options over 3,750 shares of Moleculin BiotechSEC Form 423 June 2025Common Stock · traded 20 June 2025 · filed 23 June 2025
- had shares withheld for tax on 914 shares of Moleculin BiotechSEC Form 423 June 2025Common Stock · traded 20 June 2025 · filed 23 June 2025
- exercised options over 8,990 shares of Moleculin BiotechSEC Form 423 June 2025Common Stock · traded 22 June 2025 · filed 23 June 2025
- had shares withheld for tax on 2,190 shares of Moleculin BiotechSEC Form 423 June 2025Common Stock · traded 22 June 2025 · filed 23 June 2025
- ▲ bought on the open market 675,675 shares of Moleculin BiotechSEC Form 423 June 2025Common Stock · traded 23 June 2025 · filed 23 June 2025
- exercised options over 1,667 shares of Moleculin Biotech (a derivative holding)SEC Form 418 June 2025Restricted Stock Units · traded 16 June 2025 · filed 18 June 2025
- exercised options over 1,667 shares of Moleculin BiotechSEC Form 418 June 2025Common Stock · traded 16 June 2025 · filed 18 June 2025
- had shares withheld for tax on 406 shares of Moleculin BiotechSEC Form 418 June 2025Common Stock · traded 16 June 2025 · filed 18 June 2025
- was granted 100,000 shares of Moleculin Biotech (a derivative holding)SEC Form 46 November 2024Stock option (right to buy) · traded 4 November 2024 · filed 6 November 2024
- was granted 115,000 shares of Moleculin Biotech (a derivative holding)SEC Form 46 November 2024Restricted Stock Units · traded 4 November 2024 · filed 6 November 2024
- was granted 43,590 shares of Moleculin Biotech (a derivative holding)SEC Form 46 November 2024Performance Based Restricted Stock Units · traded 25 October 2024 · filed 6 November 2024
- exercised options over 982 shares of Moleculin Biotech (a derivative holding)SEC Form 45 July 2024Restricted Stock Units · traded 2 July 2024 · filed 5 July 2024
- exercised options over 982 shares of Moleculin BiotechSEC Form 45 July 2024Common Stock · traded 2 July 2024 · filed 5 July 2024
- had shares withheld for tax on 240 shares of Moleculin BiotechSEC Form 45 July 2024Common Stock · traded 2 July 2024 · filed 5 July 2024
- exercised options over 8,990 shares of Moleculin Biotech (a derivative holding)SEC Form 425 June 2024Restricted Stock Units · traded 22 June 2024 · filed 25 June 2024
- exercised options over 8,990 shares of Moleculin BiotechSEC Form 425 June 2024Common Stock · traded 22 June 2024 · filed 25 June 2024
- had shares withheld for tax on 2,190 shares of Moleculin BiotechSEC Form 425 June 2024Common Stock · traded 22 June 2024 · filed 25 June 2024
- was granted 175,452 shares of Autonomix Medical (a derivative holding)SEC Form 424 June 2024Option (Right to buy) · traded 21 June 2024 · filed 24 June 2024
- exercised options over 3,750 shares of Moleculin Biotech (a derivative holding)SEC Form 421 June 2024Restricted Stock Units · traded 20 June 2024 · filed 21 June 2024
- exercised options over 3,750 shares of Moleculin BiotechSEC Form 421 June 2024Common Stock · traded 20 June 2024 · filed 21 June 2024
- had shares withheld for tax on 914 shares of Moleculin BiotechSEC Form 421 June 2024Common Stock · traded 20 June 2024 · filed 21 June 2024
- exercised options over 1,667 shares of Moleculin Biotech (a derivative holding)SEC Form 418 June 2024Restricted Stock Units · traded 16 June 2024 · filed 18 June 2024
- exercised options over 1,667 shares of Moleculin BiotechSEC Form 418 June 2024Common Stock · traded 16 June 2024 · filed 18 June 2024
- had shares withheld for tax on 406 shares of Moleculin BiotechSEC Form 418 June 2024Common Stock · traded 16 June 2024 · filed 18 June 2024
- ▲ bought on the open market 188,404 shares of Moleculin BiotechSEC Form 427 December 2023Common Stock · traded 26 December 2023 · filed 27 December 2023
- exercised options over 13,204 shares of Moleculin Biotech (a derivative holding)SEC Form 413 July 2023Restricted Stock Units · traded 11 July 2023 · filed 13 July 2023
- exercised options over 13,204 shares of Moleculin BiotechSEC Form 413 July 2023Common Stock · traded 11 July 2023 · filed 13 July 2023
- had shares withheld for tax on 3,216 shares of Moleculin BiotechSEC Form 413 July 2023Common Stock · traded 11 July 2023 · filed 13 July 2023
- exercised options over 14,717 shares of Moleculin Biotech (a derivative holding)SEC Form 45 July 2023Restricted Stock Units · traded 2 July 2023 · filed 5 July 2023
- exercised options over 14,717 shares of Moleculin BiotechSEC Form 45 July 2023Common Stock · traded 2 July 2023 · filed 5 July 2023
- had shares withheld for tax on 3,584 shares of Moleculin BiotechSEC Form 45 July 2023Common Stock · traded 2 July 2023 · filed 5 July 2023
- was granted 400,000 shares of Moleculin Biotech (a derivative holding)SEC Form 426 June 2023Stock option (right to buy) · traded 22 June 2023 · filed 26 June 2023
- was granted 539,375 shares of Moleculin Biotech (a derivative holding)SEC Form 426 June 2023Restricted Stock Units · traded 22 June 2023 · filed 26 June 2023
- exercised options over 56,250 shares of Moleculin Biotech (a derivative holding)SEC Form 422 June 2023Restricted Stock Units · traded 20 June 2023 · filed 22 June 2023
- exercised options over 56,250 shares of Moleculin BiotechSEC Form 422 June 2023Common Stock · traded 20 June 2023 · filed 22 June 2023
- had shares withheld for tax on 13,697 shares of Moleculin BiotechSEC Form 422 June 2023Common Stock · traded 20 June 2023 · filed 22 June 2023
- exercised options over 25,000 shares of Moleculin Biotech (a derivative holding)SEC Form 420 June 2023Restricted Stock Units · traded 16 June 2023 · filed 20 June 2023
- exercised options over 25,000 shares of Moleculin BiotechSEC Form 420 June 2023Common Stock · traded 16 June 2023 · filed 20 June 2023
- had shares withheld for tax on 6,088 shares of Moleculin BiotechSEC Form 420 June 2023Common Stock · traded 16 June 2023 · filed 20 June 2023
- ▲ bought on the open market 45,000 shares of Moleculin BiotechSEC Form 428 November 2022Common Stock · traded 25 November 2022 · filed 28 November 2022
- ▲ bought on the open market 22,500 shares of Moleculin BiotechSEC Form 423 November 2022Common Stock · traded 21 November 2022 · filed 23 November 2022
- ▲ bought on the open market 85,213 shares of Moleculin BiotechSEC Form 418 November 2022Common Stock · traded 16 November 2022 · filed 18 November 2022
- ▲ bought on the open market 24,742 shares of Moleculin BiotechSEC Form 418 November 2022Common Stock · traded 17 November 2022 · filed 18 November 2022
- was granted 225,000 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2022Stock option (right to buy) · traded 20 June 2022 · filed 15 July 2022
- was granted 225,000 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2022Restricted Stock Units · traded 20 June 2022 · filed 15 July 2022
- exercised options over 13,205 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2022Restricted Stock Units · traded 11 July 2022 · filed 15 July 2022
- exercised options over 13,204 shares of Moleculin BiotechSEC Form 415 July 2022Common Stock · traded 11 July 2022 · filed 15 July 2022
- had shares withheld for tax on 3,215 shares of Moleculin BiotechSEC Form 415 July 2022Common Stock · traded 11 July 2022 · filed 15 July 2022
- exercised options over 14,717 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2022Restricted Stock Units · traded 2 July 2022 · filed 15 July 2022
- exercised options over 14,717 shares of Moleculin BiotechSEC Form 415 July 2022Common Stock · traded 2 July 2022 · filed 15 July 2022
- had shares withheld for tax on 3,584 shares of Moleculin BiotechSEC Form 415 July 2022Common Stock · traded 2 July 2022 · filed 15 July 2022
- exercised options over 13,205 shares of Moleculin Biotech (a derivative holding)SEC Form 413 July 2022Restricted Stock Units · traded 11 July 2022 · filed 13 July 2022
- exercised options over 13,204 shares of Moleculin BiotechSEC Form 413 July 2022Common Stock · traded 11 July 2022 · filed 13 July 2022
- had shares withheld for tax on 3,215 shares of Moleculin BiotechSEC Form 413 July 2022Common Stock · traded 11 July 2022 · filed 13 July 2022
- exercised options over 14,717 shares of Moleculin Biotech (a derivative holding)SEC Form 46 July 2022Restricted Stock Units · traded 2 July 2022 · filed 6 July 2022
- exercised options over 14,717 shares of Moleculin BiotechSEC Form 46 July 2022Common Stock · traded 2 July 2022 · filed 6 July 2022
- had shares withheld for tax on 3,584 shares of Moleculin BiotechSEC Form 46 July 2022Common Stock · traded 2 July 2022 · filed 6 July 2022
- was granted 360,000 shares of Moleculin Biotech (a derivative holding)SEC Form 422 June 2022Stock option (right to buy) · traded 20 June 2022 · filed 22 June 2022
- was granted 362,000 shares of Moleculin Biotech (a derivative holding)SEC Form 422 June 2022Restricted Stock Units · traded 20 June 2022 · filed 22 June 2022
- exercised options over 25,000 shares of Moleculin Biotech (a derivative holding)SEC Form 421 June 2022Restricted Stock Units · traded 16 June 2022 · filed 21 June 2022
- exercised options over 25,000 shares of Moleculin BiotechSEC Form 421 June 2022Common Stock · traded 16 June 2022 · filed 21 June 2022
- had shares withheld for tax on 6,088 shares of Moleculin BiotechSEC Form 421 June 2022Common Stock · traded 16 June 2022 · filed 21 June 2022
- returned to the issuer 725,000 shares of Soliton (a derivative holding)SEC Form 417 December 2021Stock option (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 84,500 shares of Soliton (a derivative holding)SEC Form 417 December 2021Stock option (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 35,150 shares of Soliton (a derivative holding)SEC Form 417 December 2021Stock option (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 89,300 shares of Soliton (a derivative holding)SEC Form 417 December 2021Stock option (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 113,000 shares of Soliton (a derivative holding)SEC Form 417 December 2021Stock option (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 11,512 shares of Soliton (a derivative holding)SEC Form 417 December 2021Warrant (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 8,634 shares of Soliton (a derivative holding)SEC Form 417 December 2021Warrant (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 7,771 shares of Soliton (a derivative holding)SEC Form 417 December 2021Warrant (right to buy) · traded 16 December 2021 · filed 17 December 2021
- returned to the issuer 425,000 shares of SolitonSEC Form 417 December 2021Common Stock · traded 16 December 2021 · filed 17 December 2021
- exercised options over 13,205 shares of Moleculin BiotechSEC Form 412 July 2021Common Stock · traded 11 July 2021 · filed 12 July 2021
- had shares withheld for tax on 3,215 shares of Moleculin BiotechSEC Form 412 July 2021Common Stock · traded 11 July 2021 · filed 12 July 2021
- exercised options over 13,205 shares of Moleculin Biotech (a derivative holding)SEC Form 412 July 2021Restricted Stock Units · traded 11 July 2021 · filed 12 July 2021
- exercised options over 14,718 shares of Moleculin Biotech (a derivative holding)SEC Form 46 July 2021Restricted Stock Units · traded 2 July 2021 · filed 6 July 2021
- exercised options over 14,718 shares of Moleculin BiotechSEC Form 46 July 2021Common Stock · traded 2 July 2021 · filed 6 July 2021
- had shares withheld for tax on 3,584 shares of Moleculin BiotechSEC Form 46 July 2021Common Stock · traded 2 July 2021 · filed 6 July 2021
- was granted 223,635 shares of Moleculin Biotech (a derivative holding)SEC Form 421 June 2021Stock option (right to buy) · traded 16 June 2021 · filed 21 June 2021
- was granted 100,000 shares of Moleculin Biotech (a derivative holding)SEC Form 421 June 2021Restricted Stock Units · traded 16 June 2021 · filed 21 June 2021
- was granted 113,000 shares of Soliton (a derivative holding)SEC Form 416 April 2021Stock option (right to buy) · traded 15 April 2021 · filed 16 April 2021
- exercised options over 79,227 shares of Moleculin Biotech (a derivative holding)SEC Form 414 July 2020Restricted Stock Units · traded 13 July 2020 · filed 14 July 2020
- exercised options over 79,227 shares of Moleculin BiotechSEC Form 414 July 2020Common Stock · traded 13 July 2020 · filed 14 July 2020
- had shares withheld for tax on 19,292 shares of Moleculin BiotechSEC Form 414 July 2020Common Stock · traded 13 July 2020 · filed 14 July 2020
- was granted 500,000 shares of Moleculin Biotech (a derivative holding)SEC Form 47 July 2020Stock option (right to buy) · traded 2 July 2020 · filed 7 July 2020
- was granted 353,211 shares of Moleculin Biotech (a derivative holding)SEC Form 47 July 2020Restricted Stock Units · traded 2 July 2020 · filed 7 July 2020
- was granted 35,150 shares of Soliton (a derivative holding)SEC Form 412 February 2020Stock option (right to buy) · traded 27 June 2019 · filed 12 February 2020
- was granted 89,300 shares of Soliton (a derivative holding)SEC Form 412 February 2020Stock option (right to buy) · traded 4 February 2020 · filed 12 February 2020
- was granted 500,000 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2019Stock option (right to buy) · traded 11 July 2019 · filed 15 July 2019
- was granted 316,907 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2019Restricted Stock Units · traded 11 July 2019 · filed 15 July 2019
- was granted 500,000 shares of Moleculin Biotech (a derivative holding)SEC Form 415 July 2019Stock option (right to buy) · traded 6 June 2018 · filed 15 July 2019
- was granted 35,150 shares of Soliton (a derivative holding)SEC Form 41 July 2019Stock option (right to buy) · traded 27 June 2019 · filed 1 July 2019
- was granted 603,000 shares of Moleculin Biotech (a derivative holding)SEC Form 48 June 2018Stock option (right to buy) · traded 6 June 2018 · filed 8 June 2018
- was granted 340,000 shares of Moleculin Biotech (a derivative holding)SEC Form 45 October 2017Stock option (right to buy) · traded 3 October 2017 · filed 5 October 2017
- ▼ sold on the open market 100,000 shares of Moleculin BiotechSEC Form 418 August 2017Common Stock · traded 16 August 2017 · filed 18 August 2017
- ▲ bought on the open market 12,000 shares of Moleculin BiotechSEC Form 412 May 2017Common Stock · traded 11 May 2017 · filed 12 May 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.